Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trialMan‐Fung Yuen, T. Jesse Kwoh, Jeong Heo et al.|Nature Medicine|2021Cited by 156
674PDelpacibart zotadirsen (del-zota) increased dystrophin and improved muscle integrity markers regardless of ambulatory status in individuals with DMD44Aravindhan Veerapandiyan, Elizabeth Ackermann, Carolina Tesi Rocha et al.|Neuromuscular Disorders|2025Cited by 1
Del-Zota Produced Statistically Significant Increases in Exon Skipping and Dystrophin Levels in EXPLORE44: A Phase 1/2 Study in Patients with DMD44Aravindhan Veerapandiyan, Elizabeth Ackermann, Jamie M. Eskuri et al.|Neuropediatrics|2025Cited by 0